Results 241 to 250 of about 807,103 (307)
Acute mitral regurgitation after transcatheter tricuspid valve replacement - case report. [PDF]
Rubinic B +4 more
europepmc +1 more source
ABSTRACT Energy efficiency is recognized as a cornerstone for industrial decarbonization, yet its uptake remains very limited in the manufacturing firms leading to energy efficiency gap. Whilst the low uptake of energy efficiency measures in industry is a well‐known issue, research has not sufficiently investigated the role of comprehensive factors in ...
Davide Accordini +3 more
wiley +1 more source
Transcatheter Aortic Valve Replacement in a Failed Homograft. [PDF]
Reisinger M +6 more
europepmc +1 more source
Regenerative perfusion bioreactor for biologics production with lower COGs
Abstract Perfusion bioreactor systems enable intensified bioprocessing with high cell densities and volumetric productivities in monoclonal antibody (mAb) manufacturing. However, their widespread adoption remains constrained by the high consumption of chemically defined cell culture media.
Eric Wynne +5 more
wiley +1 more source
Redo surgical aortic valve replacement versus valve-in-valve transcatheter aortic valve replacement with balloon valve fracture: Short-term clinical outcomes. [PDF]
Kanade R +14 more
europepmc +1 more source
ABSTRACT Percutaneous transaxillary access is an established alternative to transfemoral large‐bore arterial access for transcatheter structural heart interventions and mechanical circulatory support (MCS). Although useful for overcoming hostile iliofemoral anatomy and providing prolonged support and patient mobilization in case of MCS, the axillary ...
Gioel Gabrio Secco +9 more
wiley +1 more source
Management of Bioprosthetic Valve Thrombosis Following Transcatheter Mitral Valve Replacement. [PDF]
Davidson N, Murdoch D, Gurvitch R.
europepmc +1 more source
ABSTRACT Background Preprocedural planning with multislice computed tomography (MSCT) is an essential prerequisite for successful transcatheter aortic valve replacement (TAVR). However, preprocedural planning is time‐consuming and may contain clinically meaningful interobserver variability.
Mark M. P. van den Dorpel +11 more
wiley +1 more source
Early Outcomes of Real-World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population. [PDF]
Xu H, Yan Y, Chen X, Wang J, Sun H.
europepmc +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source

